Elizabeth Grace Rocco, MD | |
355 Main St, Cambridge, MA 02142-1062 | |
(617) 903-5000 | |
Not Available |
Full Name | Elizabeth Grace Rocco |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 355 Main St, Cambridge, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073597530 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 219675 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Grace Rocco, MD 73d Winthrop Ave, Plaza 114, Lawrence, MA 01843-3716 Ph: (978) 686-3017 | Elizabeth Grace Rocco, MD 355 Main St, Cambridge, MA 02142-1062 Ph: (617) 903-5000 |
News Archive
The new study, which used mathematical models to simulate the outcome of screening the whole population, estimates that between 158 million and 306 million people would be referred for confirmatory testing, but only 26-37 million of those would meet the diagnostic criteria for diabetes...
Barrett's epithelium is recognized as a complication of erosive esophagitis and is the pre-malignant condition for adenocarcinoma of the esophagus.
Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers.
The U.S. Food and Drug Administration today approved a new use for Botox Cosmetic (onabotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines, known as crow's feet, in adults. Botox Cosmetic is the only FDA approved drug treatment option for lateral canthal lines.
Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.
› Verified 3 days ago
Katherine E Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Windsor St, Cambridge, MA 02139 Phone: 617-665-3370 | |
Md Sheikh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2067 Massachusetts Ave, Cambridge, MA 02140 Phone: 617-575-5550 | |
Randy F Wertheimer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, 1320 Macht Bldg, Cambridge, MA 02139 Phone: 617-665-1117 | |
Rachid Chakri, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Binney St, Cambridge, MA 02142 Phone: 617-903-5000 | |
Alexandra B. Houck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Mount Auburn St, Cambridge, MA 02138 Phone: 617-495-8414 Fax: 617-496-0560 | |
Sherry A. Graham, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 822 Somerville Ave, Cambridge, MA 02140 Phone: 617-903-5000 |